XILLIX FDA APPROVED Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XILLIX FDA APPROVED

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Edward W. Richmond who wrote (379)	2/26/1999 10:59:00 PM
From: Robert Dydo	Read Replies (1) of 572

I must admit that I was surprise with the results of the last quarter. It was a positive surprise overall. I am disappointed with lack of response or even a decline in price. Last quarter showed a very improved picture of Xillix. The only question is when the growth can be sustained on regular basis not as before if it is possible. Last quarter is the indication that with improvement of sales, company can quickly become profitable with the $ value which is still a small drop against ocean of possibilities. The fundamental evaluation of the company will be clearer and this should in time bring more interest to the stock. Hopefully with every quarter we will be counting earnings per share, which should make price of 1.04 a bargain of long gone past. I feel reassured in success for the long term.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next